Uncertain outcomes: Adjusting for misclassification in antimalarial efficacy studies

Epidemiology and Infection

Volumn 139, Issue 4, 2011, Pages 544-551

  Porter, K A ^a   Burch, C L ^b   Poole, C ^a   Juliano, J J ^b   Cole, S R ^a   Meshnick, S R ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Infectious disease epidemiology; malaria

Indexed keywords

ALLELE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE TRANSMISSION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENETIC VARIABILITY; MALARIA; MALARIA CONTROL; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RECURRENT INFECTION; REINFECTION; SYSTEMATIC ERROR; HUMAN; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; METHODOLOGY; PARASITOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ANTIMALARIAL AGENT;

ANTIMALARIALS; BIOMEDICAL RESEARCH; FALSE POSITIVE REACTIONS; HUMANS; MALARIA; PARASITOLOGY; POLYMERASE CHAIN REACTION; RECURRENCE; TREATMENT OUTCOME;

EID: 79955685158     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810001652     Document Type: Article

References (18)

1. World Health Organization. Guidelines for the treatment of malaria (http://apps.who.int/malaria/docs/TreatmentGuidelines2006.pdf). Accessed 10 August 2009.
2. Collins WJ, et al. The use of genotyping in antimalarial clinical trials : a systematic review of published studies from 1995-2005. Malaria Journal 2006; 5: 122.
3. Guthmann JP, et al. Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrobial Agents and Chemotherapy 2006; 50: 3734-3739.
4. Medicines for Malaria Venture and the World Health Organization. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Proceedings of meeting, 2007. The Netherlands.
5. Greenhouse B, et al. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Antimicrobial Agents and Chemotherapy 2007; 51: 3096-3103. (Pubitemid 350067514)
6. Kwiek JJ, et al. Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections. Antimicrobial Agents and Chemotherapy 2007; 51: 521-527. (Pubitemid 46185269)
7. Juliano JJ, Taylor SM, Meshnick SR. Polymerase chain reaction adjustment in antimalarial trials : molecular malarkey? Journal of Infectious Diseases 2009; 200: 5-7.
8. Juliano JJ, et al. Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia. Journal of Infectious Diseases 2009; 200: 624-628.
9. Jurek AM, et al. Uncertainty analysis : an example of its application to estimating a survey proportion. Journal of Epidemiology and Community Health 2007; 61: 650-654. (Pubitemid 46998900)
10. Vose D. Risk Analysis : A Quantitative Guide, 2nd edn, 2000: West Sussex: John Wiley & Sons Ltd, pp. 181-184.
11. Bukirwa H, et al. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clinical Trials 2006; 1: e7.
12. Zongo I, et al. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria : a randomized controlled trial from Burkina Faso. American Journal of Tropical Medicine and Hygiene 2005; 73: 826-832. (Pubitemid 41688453)
13. Brockman A, et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. American Journal of Tropical Medicine and Hygiene 1999; 60: 14-21. (Pubitemid 29065997)
14. Gatton ML, Cheng Q. Can estimates of antimalarial efficacy from field studies be improved? Trends in Parasitology 2008; 24: 68-73.
15. Juliano JJ, et al. Detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay. American Journal of Tropical Medicine and Hygiene 2008; 78: 892-894. (Pubitemid 351967805)
16. Juliano JJ, et al. Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi. Emerging Infectious Diseases 2007; 13: 872-877.
17. Ngrenngarmlert W, et al. Measuring allelic heterogeneity in Plasmodium falciparum by a heteroduplex tracking assay. American Journal of Tropical Medicine and Hygiene 2005; 72: 694-701. (Pubitemid 41278786)
18. Greenland S. Interval estimation by simulation as an alternative to and extension of confidence intervals. International Journal of Epidemiology 2004; 33: 1389-1397. (Pubitemid 40124946)